Risks to Donors in Bone Marrow Transplants

Registering with the National Marrow Donor Program takes only minutes. You receive a kit in the mail afterwards which includes some swabs. You swab your cheek with these swabs and put them into the kit and mail it back to the National Marrow Donor Program. Eventually you enter their records, and one day in the future you may be fortunate enough to be a match for a person desperately in need of blood stem cells.

There are many, many risks associated with being the recipient of another person's blood stem cells, including death.

But being a donor? There is almost no risk to a donor's health at all.

Cell Sources

Donors may be asked to donate either bone marrow or peripheral blood stem cells (stem cells in circulation in your body). Donating bone marrow is much easier—health professionals give the patient either local or general anesthetic, then stick a needle into the back of the pelvic bone and draw out some sponge-like marrow. That's the extent of the procedure for the donor, who might have some minor back pain for a couple of days.

Donating peripheral stem cells is a little more involved. For about a week prior to the actual day of donation, the donor is required to be given an injection of a medication called filgrastim that boosts the body's production of those stem cells so that in a week's time, there are plenty in the body to donate. When that day comes, an IV goes into each arm. One removes blood from the body and passes it through a large device that takes out the blood stem cells. The remaining blood is then returned to the patient via the other IV.

Prior to the collection date, the donor might experience a headache or some bone or muscle aches. All this passes shortly following the collection date.

Risks

The risks associated with donating blood stem cells are the same as donating blood in a blood drive—maybe some swelling or redness at the injection site. Complications are otherwise so minimal as to almost be a non-issue, especially considering the potential gift of life the donor is offering a needy patient.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap